2014 annual financial data

BioCryst Pharmaceuticals 2014 Net margin

BioCryst Pharmaceuticals 2014 net margin with verified reported values.

Direct answer

Net margin was -332.08%.

Operating income was -45,771,000 USD and net income was -45,189,000 USD.
Operating cash flow was -38,551,000 USD.

Get free BioCryst Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
13,608,000 USD
Operating income
-45,771,000 USD
Net income
-45,189,000 USD
Operating cash flow
-38,551,000 USD